nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR7—skin cancer	0.695	1	CbGaD
Imiquimod—CYP1A2—Vemurafenib—skin cancer	0.0368	0.22	CbGbCtD
Imiquimod—CYP3A4—Temozolomide—skin cancer	0.0352	0.211	CbGbCtD
Imiquimod—CYP1A2—Dacarbazine—skin cancer	0.0282	0.169	CbGbCtD
Imiquimod—CYP3A4—Vismodegib—skin cancer	0.0244	0.146	CbGbCtD
Imiquimod—CYP3A4—Vemurafenib—skin cancer	0.0193	0.115	CbGbCtD
Imiquimod—CYP1A2—Fluorouracil—skin cancer	0.0165	0.099	CbGbCtD
Imiquimod—TLR8—TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling—TLR7—skin cancer	0.0117	0.302	CbGpPWpGaD
Imiquimod—TLR8—Trafficking and processing of endosomal TLR—TLR7—skin cancer	0.0103	0.265	CbGpPWpGaD
Imiquimod—CYP3A4—Docetaxel—skin cancer	0.00661	0.0396	CbGbCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TLR7—skin cancer	0.00227	0.0584	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—TLR7—skin cancer	0.00222	0.0573	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—TLR7—skin cancer	0.00215	0.0553	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TLR7—skin cancer	0.00198	0.0509	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR7—skin cancer	0.00154	0.0397	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00153	0.0393	CbGpPWpGaD
Imiquimod—TLR8—lymphoid tissue—skin cancer	0.00126	0.226	CbGeAlD
Imiquimod—TLR8—female reproductive system—skin cancer	0.00121	0.218	CbGeAlD
Imiquimod—TLR7—lymphoid tissue—skin cancer	0.000793	0.143	CbGeAlD
Imiquimod—TLR7—female reproductive system—skin cancer	0.000765	0.138	CbGeAlD
Imiquimod—TLR8—lymph node—skin cancer	0.000709	0.128	CbGeAlD
Imiquimod—TLR8—Innate Immune System—TLR7—skin cancer	0.000494	0.0127	CbGpPWpGaD
Imiquimod—TLR7—lymph node—skin cancer	0.000447	0.0805	CbGeAlD
Imiquimod—TLR8—Immune System—TLR7—skin cancer	0.000288	0.00741	CbGpPWpGaD
Imiquimod—CYP1A2—nipple—skin cancer	0.000275	0.0495	CbGeAlD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.000272	0.007	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000267	0.00687	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000257	0.00663	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—FOXO4—skin cancer	0.000254	0.00656	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000237	0.0061	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.000206	0.0053	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000202	0.00521	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000195	0.00502	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FOXO4—skin cancer	0.000193	0.00497	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000185	0.00477	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—skin cancer	0.000183	0.00471	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.00018	0.00463	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FOXO4—skin cancer	0.000148	0.00382	CbGpPWpGaD
Imiquimod—Erythema multiforme—Dactinomycin—skin cancer	0.000142	0.00151	CcSEcCtD
Imiquimod—Sinusitis—Temozolomide—skin cancer	0.000142	0.00151	CcSEcCtD
Imiquimod—Erythema—Bleomycin—skin cancer	0.000141	0.00149	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.00014	0.00361	CbGpPWpGaD
Imiquimod—Infestation—Fluorouracil—skin cancer	0.00014	0.00148	CcSEcCtD
Imiquimod—Infestation NOS—Fluorouracil—skin cancer	0.00014	0.00148	CcSEcCtD
Imiquimod—Flushing—Dactinomycin—skin cancer	0.00014	0.00148	CcSEcCtD
Imiquimod—Hypersensitivity—Vemurafenib—skin cancer	0.000139	0.00148	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—skin cancer	0.000139	0.00357	CbGpPWpGaD
Imiquimod—Atrial fibrillation—Docetaxel—skin cancer	0.000138	0.00147	CcSEcCtD
Imiquimod—Acute coronary syndrome—Fluorouracil—skin cancer	0.000138	0.00146	CcSEcCtD
Imiquimod—Neuropathy peripheral—Fluorouracil—skin cancer	0.000137	0.00145	CcSEcCtD
Imiquimod—Myocardial infarction—Fluorouracil—skin cancer	0.000137	0.00145	CcSEcCtD
Imiquimod—Haemoglobin—Temozolomide—skin cancer	0.000137	0.00145	CcSEcCtD
Imiquimod—Haemorrhage—Temozolomide—skin cancer	0.000136	0.00145	CcSEcCtD
Imiquimod—Conjunctivitis—Fluorouracil—skin cancer	0.000136	0.00144	CcSEcCtD
Imiquimod—Urinary tract infection—Fluorouracil—skin cancer	0.000136	0.00144	CcSEcCtD
Imiquimod—Asthenia—Vemurafenib—skin cancer	0.000136	0.00144	CcSEcCtD
Imiquimod—Pharyngitis—Temozolomide—skin cancer	0.000135	0.00143	CcSEcCtD
Imiquimod—Chills—Dactinomycin—skin cancer	0.000135	0.00143	CcSEcCtD
Imiquimod—Urinary tract disorder—Temozolomide—skin cancer	0.000134	0.00143	CcSEcCtD
Imiquimod—Cardiac failure—Docetaxel—skin cancer	0.000134	0.00142	CcSEcCtD
Imiquimod—Pruritus—Vemurafenib—skin cancer	0.000134	0.00142	CcSEcCtD
Imiquimod—Connective tissue disorder—Temozolomide—skin cancer	0.000134	0.00142	CcSEcCtD
Imiquimod—Lethargy—Docetaxel—skin cancer	0.000134	0.00142	CcSEcCtD
Imiquimod—Urethral disorder—Temozolomide—skin cancer	0.000134	0.00142	CcSEcCtD
Imiquimod—Alopecia—Dactinomycin—skin cancer	0.000133	0.00141	CcSEcCtD
Imiquimod—Visual impairment—Temozolomide—skin cancer	0.000131	0.00139	CcSEcCtD
Imiquimod—Sinusitis—Fluorouracil—skin cancer	0.000131	0.00139	CcSEcCtD
Imiquimod—Erythema—Dactinomycin—skin cancer	0.000131	0.00139	CcSEcCtD
Imiquimod—Pain in extremity—Docetaxel—skin cancer	0.000131	0.00139	CcSEcCtD
Imiquimod—Ill-defined disorder—Bleomycin—skin cancer	0.00013	0.00138	CcSEcCtD
Imiquimod—Diarrhoea—Vemurafenib—skin cancer	0.00013	0.00137	CcSEcCtD
Imiquimod—Migraine—Docetaxel—skin cancer	0.000129	0.00137	CcSEcCtD
Imiquimod—Erythema multiforme—Temozolomide—skin cancer	0.000129	0.00137	CcSEcCtD
Imiquimod—Eye disorder—Temozolomide—skin cancer	0.000127	0.00135	CcSEcCtD
Imiquimod—Tinnitus—Temozolomide—skin cancer	0.000127	0.00135	CcSEcCtD
Imiquimod—Malaise—Bleomycin—skin cancer	0.000127	0.00134	CcSEcCtD
Imiquimod—Flushing—Temozolomide—skin cancer	0.000126	0.00134	CcSEcCtD
Imiquimod—Haemoglobin—Fluorouracil—skin cancer	0.000126	0.00134	CcSEcCtD
Imiquimod—Rhinitis—Fluorouracil—skin cancer	0.000126	0.00133	CcSEcCtD
Imiquimod—Haemorrhage—Fluorouracil—skin cancer	0.000125	0.00133	CcSEcCtD
Imiquimod—Dizziness—Vemurafenib—skin cancer	0.000125	0.00133	CcSEcCtD
Imiquimod—Pharyngitis—Fluorouracil—skin cancer	0.000125	0.00132	CcSEcCtD
Imiquimod—Angiopathy—Temozolomide—skin cancer	0.000124	0.00131	CcSEcCtD
Imiquimod—Immune system disorder—Temozolomide—skin cancer	0.000123	0.00131	CcSEcCtD
Imiquimod—Mediastinal disorder—Temozolomide—skin cancer	0.000123	0.0013	CcSEcCtD
Imiquimod—Cough—Bleomycin—skin cancer	0.000123	0.0013	CcSEcCtD
Imiquimod—Chills—Temozolomide—skin cancer	0.000122	0.0013	CcSEcCtD
Imiquimod—Ill-defined disorder—Dactinomycin—skin cancer	0.000122	0.00129	CcSEcCtD
Imiquimod—Vomiting—Vemurafenib—skin cancer	0.00012	0.00128	CcSEcCtD
Imiquimod—Alopecia—Temozolomide—skin cancer	0.00012	0.00128	CcSEcCtD
Imiquimod—Chest pain—Bleomycin—skin cancer	0.00012	0.00127	CcSEcCtD
Imiquimod—Myalgia—Bleomycin—skin cancer	0.00012	0.00127	CcSEcCtD
Imiquimod—Rash—Vemurafenib—skin cancer	0.000119	0.00127	CcSEcCtD
Imiquimod—Mental disorder—Temozolomide—skin cancer	0.000119	0.00127	CcSEcCtD
Imiquimod—Dermatitis—Vemurafenib—skin cancer	0.000119	0.00127	CcSEcCtD
Imiquimod—Headache—Vemurafenib—skin cancer	0.000119	0.00126	CcSEcCtD
Imiquimod—Malnutrition—Temozolomide—skin cancer	0.000119	0.00126	CcSEcCtD
Imiquimod—Erythema—Temozolomide—skin cancer	0.000119	0.00126	CcSEcCtD
Imiquimod—Breast disorder—Docetaxel—skin cancer	0.000118	0.00126	CcSEcCtD
Imiquimod—Discomfort—Bleomycin—skin cancer	0.000118	0.00125	CcSEcCtD
Imiquimod—Malaise—Dactinomycin—skin cancer	0.000118	0.00125	CcSEcCtD
Imiquimod—Oedema—Bleomycin—skin cancer	0.000115	0.00122	CcSEcCtD
Imiquimod—Back pain—Temozolomide—skin cancer	0.000115	0.00122	CcSEcCtD
Imiquimod—Infection—Bleomycin—skin cancer	0.000114	0.00121	CcSEcCtD
Imiquimod—Nausea—Vemurafenib—skin cancer	0.000112	0.00119	CcSEcCtD
Imiquimod—TLR7—Immune System—FOXO4—skin cancer	0.000112	0.00289	CbGpPWpGaD
Imiquimod—Arrhythmia—Fluorouracil—skin cancer	0.000112	0.00119	CcSEcCtD
Imiquimod—Myalgia—Dactinomycin—skin cancer	0.000112	0.00118	CcSEcCtD
Imiquimod—Alopecia—Fluorouracil—skin cancer	0.000111	0.00118	CcSEcCtD
Imiquimod—Discomfort—Dactinomycin—skin cancer	0.00011	0.00117	CcSEcCtD
Imiquimod—Ill-defined disorder—Temozolomide—skin cancer	0.00011	0.00117	CcSEcCtD
Imiquimod—Anorexia—Bleomycin—skin cancer	0.000109	0.00116	CcSEcCtD
Imiquimod—Erythema—Fluorouracil—skin cancer	0.000109	0.00116	CcSEcCtD
Imiquimod—Agitation—Temozolomide—skin cancer	0.000109	0.00116	CcSEcCtD
Imiquimod—Angioedema—Temozolomide—skin cancer	0.000108	0.00115	CcSEcCtD
Imiquimod—Pancytopenia—Docetaxel—skin cancer	0.000107	0.00114	CcSEcCtD
Imiquimod—Oedema—Dactinomycin—skin cancer	0.000107	0.00114	CcSEcCtD
Imiquimod—Malaise—Temozolomide—skin cancer	0.000107	0.00113	CcSEcCtD
Imiquimod—Infection—Dactinomycin—skin cancer	0.000106	0.00113	CcSEcCtD
Imiquimod—Palpitations—Temozolomide—skin cancer	0.000105	0.00111	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000105	0.00111	CcSEcCtD
Imiquimod—Cough—Temozolomide—skin cancer	0.000103	0.0011	CcSEcCtD
Imiquimod—Paraesthesia—Bleomycin—skin cancer	0.000103	0.00109	CcSEcCtD
Imiquimod—Convulsion—Temozolomide—skin cancer	0.000103	0.00109	CcSEcCtD
Imiquimod—Hypertension—Temozolomide—skin cancer	0.000102	0.00109	CcSEcCtD
Imiquimod—Dyspnoea—Bleomycin—skin cancer	0.000102	0.00109	CcSEcCtD
Imiquimod—Anorexia—Dactinomycin—skin cancer	0.000102	0.00108	CcSEcCtD
Imiquimod—Arthralgia—Temozolomide—skin cancer	0.000101	0.00107	CcSEcCtD
Imiquimod—Myalgia—Temozolomide—skin cancer	0.000101	0.00107	CcSEcCtD
Imiquimod—Infestation NOS—Docetaxel—skin cancer	0.000101	0.00107	CcSEcCtD
Imiquimod—Infestation—Docetaxel—skin cancer	0.000101	0.00107	CcSEcCtD
Imiquimod—Anxiety—Temozolomide—skin cancer	0.000101	0.00107	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.0001	0.00106	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.0001	0.00106	CcSEcCtD
Imiquimod—Discomfort—Temozolomide—skin cancer	9.97e-05	0.00106	CcSEcCtD
Imiquimod—Decreased appetite—Bleomycin—skin cancer	9.97e-05	0.00106	CcSEcCtD
Imiquimod—CYP3A4—female reproductive system—skin cancer	9.97e-05	0.0179	CbGeAlD
Imiquimod—Acute coronary syndrome—Docetaxel—skin cancer	9.95e-05	0.00106	CcSEcCtD
Imiquimod—Myocardial infarction—Docetaxel—skin cancer	9.89e-05	0.00105	CcSEcCtD
Imiquimod—Neuropathy peripheral—Docetaxel—skin cancer	9.89e-05	0.00105	CcSEcCtD
Imiquimod—Dry mouth—Temozolomide—skin cancer	9.87e-05	0.00105	CcSEcCtD
Imiquimod—Pain—Bleomycin—skin cancer	9.81e-05	0.00104	CcSEcCtD
Imiquimod—Conjunctivitis—Docetaxel—skin cancer	9.81e-05	0.00104	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Dactinomycin—skin cancer	9.75e-05	0.00103	CcSEcCtD
Imiquimod—Oedema—Temozolomide—skin cancer	9.68e-05	0.00103	CcSEcCtD
Imiquimod—Infection—Temozolomide—skin cancer	9.61e-05	0.00102	CcSEcCtD
Imiquimod—Hepatobiliary disease—Docetaxel—skin cancer	9.54e-05	0.00101	CcSEcCtD
Imiquimod—Nervous system disorder—Temozolomide—skin cancer	9.49e-05	0.00101	CcSEcCtD
Imiquimod—Convulsion—Fluorouracil—skin cancer	9.46e-05	0.001	CcSEcCtD
Imiquimod—Feeling abnormal—Bleomycin—skin cancer	9.45e-05	0.001	CcSEcCtD
Imiquimod—Skin disorder—Temozolomide—skin cancer	9.4e-05	0.000997	CcSEcCtD
Imiquimod—Hyperhidrosis—Temozolomide—skin cancer	9.35e-05	0.000992	CcSEcCtD
Imiquimod—Chest pain—Fluorouracil—skin cancer	9.3e-05	0.000987	CcSEcCtD
Imiquimod—Myalgia—Fluorouracil—skin cancer	9.3e-05	0.000987	CcSEcCtD
Imiquimod—Decreased appetite—Dactinomycin—skin cancer	9.3e-05	0.000987	CcSEcCtD
Imiquimod—Fatigue—Dactinomycin—skin cancer	9.22e-05	0.000979	CcSEcCtD
Imiquimod—Anorexia—Temozolomide—skin cancer	9.22e-05	0.000979	CcSEcCtD
Imiquimod—Discomfort—Fluorouracil—skin cancer	9.19e-05	0.000975	CcSEcCtD
Imiquimod—Pain—Dactinomycin—skin cancer	9.15e-05	0.000971	CcSEcCtD
Imiquimod—Urticaria—Bleomycin—skin cancer	9.11e-05	0.000967	CcSEcCtD
Imiquimod—Haemoglobin—Docetaxel—skin cancer	9.1e-05	0.000966	CcSEcCtD
Imiquimod—Rhinitis—Docetaxel—skin cancer	9.08e-05	0.000963	CcSEcCtD
Imiquimod—Body temperature increased—Bleomycin—skin cancer	9.07e-05	0.000962	CcSEcCtD
Imiquimod—Haemorrhage—Docetaxel—skin cancer	9.06e-05	0.000961	CcSEcCtD
Imiquimod—Pharyngitis—Docetaxel—skin cancer	8.99e-05	0.000954	CcSEcCtD
Imiquimod—Urinary tract disorder—Docetaxel—skin cancer	8.94e-05	0.000949	CcSEcCtD
Imiquimod—Oedema—Fluorouracil—skin cancer	8.92e-05	0.000946	CcSEcCtD
Imiquimod—Connective tissue disorder—Docetaxel—skin cancer	8.9e-05	0.000944	CcSEcCtD
Imiquimod—Urethral disorder—Docetaxel—skin cancer	8.88e-05	0.000942	CcSEcCtD
Imiquimod—Infection—Fluorouracil—skin cancer	8.86e-05	0.00094	CcSEcCtD
Imiquimod—Feeling abnormal—Dactinomycin—skin cancer	8.82e-05	0.000935	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Temozolomide—skin cancer	8.82e-05	0.000935	CcSEcCtD
Imiquimod—Insomnia—Temozolomide—skin cancer	8.75e-05	0.000929	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dactinomycin—skin cancer	8.75e-05	0.000928	CcSEcCtD
Imiquimod—Nervous system disorder—Fluorouracil—skin cancer	8.74e-05	0.000928	CcSEcCtD
Imiquimod—Visual impairment—Docetaxel—skin cancer	8.73e-05	0.000926	CcSEcCtD
Imiquimod—Tachycardia—Fluorouracil—skin cancer	8.7e-05	0.000923	CcSEcCtD
Imiquimod—Paraesthesia—Temozolomide—skin cancer	8.69e-05	0.000922	CcSEcCtD
Imiquimod—Dyspnoea—Temozolomide—skin cancer	8.63e-05	0.000915	CcSEcCtD
Imiquimod—Somnolence—Temozolomide—skin cancer	8.6e-05	0.000913	CcSEcCtD
Imiquimod—Erythema multiforme—Docetaxel—skin cancer	8.56e-05	0.000909	CcSEcCtD
Imiquimod—Dyspepsia—Temozolomide—skin cancer	8.52e-05	0.000904	CcSEcCtD
Imiquimod—Anorexia—Fluorouracil—skin cancer	8.5e-05	0.000902	CcSEcCtD
Imiquimod—Eye disorder—Docetaxel—skin cancer	8.46e-05	0.000898	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NRAS—skin cancer	8.46e-05	0.00218	CbGpPWpGaD
Imiquimod—Abdominal pain—Dactinomycin—skin cancer	8.46e-05	0.000897	CcSEcCtD
Imiquimod—Body temperature increased—Dactinomycin—skin cancer	8.46e-05	0.000897	CcSEcCtD
Imiquimod—Hypersensitivity—Bleomycin—skin cancer	8.45e-05	0.000897	CcSEcCtD
Imiquimod—Decreased appetite—Temozolomide—skin cancer	8.41e-05	0.000892	CcSEcCtD
Imiquimod—Flushing—Docetaxel—skin cancer	8.41e-05	0.000892	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Temozolomide—skin cancer	8.35e-05	0.000886	CcSEcCtD
Imiquimod—Fatigue—Temozolomide—skin cancer	8.34e-05	0.000885	CcSEcCtD
Imiquimod—Pain—Temozolomide—skin cancer	8.27e-05	0.000878	CcSEcCtD
Imiquimod—Asthenia—Bleomycin—skin cancer	8.23e-05	0.000873	CcSEcCtD
Imiquimod—Angiopathy—Docetaxel—skin cancer	8.22e-05	0.000872	CcSEcCtD
Imiquimod—Immune system disorder—Docetaxel—skin cancer	8.18e-05	0.000868	CcSEcCtD
Imiquimod—Mediastinal disorder—Docetaxel—skin cancer	8.16e-05	0.000866	CcSEcCtD
Imiquimod—Chills—Docetaxel—skin cancer	8.13e-05	0.000862	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Fluorouracil—skin cancer	8.12e-05	0.000862	CcSEcCtD
Imiquimod—Pruritus—Bleomycin—skin cancer	8.12e-05	0.000861	CcSEcCtD
Imiquimod—Arrhythmia—Docetaxel—skin cancer	8.09e-05	0.000858	CcSEcCtD
Imiquimod—Insomnia—Fluorouracil—skin cancer	8.06e-05	0.000856	CcSEcCtD
Imiquimod—Paraesthesia—Fluorouracil—skin cancer	8.01e-05	0.000849	CcSEcCtD
Imiquimod—Alopecia—Docetaxel—skin cancer	8e-05	0.000849	CcSEcCtD
Imiquimod—Feeling abnormal—Temozolomide—skin cancer	7.97e-05	0.000846	CcSEcCtD
Imiquimod—Dyspnoea—Fluorouracil—skin cancer	7.95e-05	0.000843	CcSEcCtD
Imiquimod—Mental disorder—Docetaxel—skin cancer	7.93e-05	0.000842	CcSEcCtD
Imiquimod—Somnolence—Fluorouracil—skin cancer	7.93e-05	0.000841	CcSEcCtD
Imiquimod—Gastrointestinal pain—Temozolomide—skin cancer	7.91e-05	0.000839	CcSEcCtD
Imiquimod—Erythema—Docetaxel—skin cancer	7.88e-05	0.000837	CcSEcCtD
Imiquimod—Malnutrition—Docetaxel—skin cancer	7.88e-05	0.000837	CcSEcCtD
Imiquimod—Hypersensitivity—Dactinomycin—skin cancer	7.88e-05	0.000836	CcSEcCtD
Imiquimod—Dyspepsia—Fluorouracil—skin cancer	7.85e-05	0.000833	CcSEcCtD
Imiquimod—Decreased appetite—Fluorouracil—skin cancer	7.75e-05	0.000822	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Fluorouracil—skin cancer	7.7e-05	0.000817	CcSEcCtD
Imiquimod—Urticaria—Temozolomide—skin cancer	7.69e-05	0.000816	CcSEcCtD
Imiquimod—Asthenia—Dactinomycin—skin cancer	7.68e-05	0.000814	CcSEcCtD
Imiquimod—Body temperature increased—Temozolomide—skin cancer	7.65e-05	0.000812	CcSEcCtD
Imiquimod—Abdominal pain—Temozolomide—skin cancer	7.65e-05	0.000812	CcSEcCtD
Imiquimod—Back pain—Docetaxel—skin cancer	7.63e-05	0.000809	CcSEcCtD
Imiquimod—Pain—Fluorouracil—skin cancer	7.62e-05	0.000809	CcSEcCtD
Imiquimod—Feeling abnormal—Fluorouracil—skin cancer	7.35e-05	0.000779	CcSEcCtD
Imiquimod—Diarrhoea—Dactinomycin—skin cancer	7.32e-05	0.000777	CcSEcCtD
Imiquimod—Vomiting—Bleomycin—skin cancer	7.29e-05	0.000774	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—KRAS—skin cancer	7.28e-05	0.00188	CbGpPWpGaD
Imiquimod—Rash—Bleomycin—skin cancer	7.23e-05	0.000767	CcSEcCtD
Imiquimod—Dermatitis—Bleomycin—skin cancer	7.23e-05	0.000767	CcSEcCtD
Imiquimod—Hypersensitivity—Temozolomide—skin cancer	7.13e-05	0.000756	CcSEcCtD
Imiquimod—Urticaria—Fluorouracil—skin cancer	7.08e-05	0.000751	CcSEcCtD
Imiquimod—Syncope—Docetaxel—skin cancer	7.07e-05	0.00075	CcSEcCtD
Imiquimod—Body temperature increased—Fluorouracil—skin cancer	7.05e-05	0.000748	CcSEcCtD
Imiquimod—Palpitations—Docetaxel—skin cancer	6.97e-05	0.000739	CcSEcCtD
Imiquimod—Asthenia—Temozolomide—skin cancer	6.94e-05	0.000737	CcSEcCtD
Imiquimod—Loss of consciousness—Docetaxel—skin cancer	6.93e-05	0.000735	CcSEcCtD
Imiquimod—Cough—Docetaxel—skin cancer	6.88e-05	0.00073	CcSEcCtD
Imiquimod—Pruritus—Temozolomide—skin cancer	6.85e-05	0.000726	CcSEcCtD
Imiquimod—Convulsion—Docetaxel—skin cancer	6.83e-05	0.000725	CcSEcCtD
Imiquimod—Nausea—Bleomycin—skin cancer	6.81e-05	0.000723	CcSEcCtD
Imiquimod—Hypertension—Docetaxel—skin cancer	6.81e-05	0.000722	CcSEcCtD
Imiquimod—Vomiting—Dactinomycin—skin cancer	6.8e-05	0.000722	CcSEcCtD
Imiquimod—Rash—Dactinomycin—skin cancer	6.75e-05	0.000716	CcSEcCtD
Imiquimod—Arthralgia—Docetaxel—skin cancer	6.71e-05	0.000712	CcSEcCtD
Imiquimod—Myalgia—Docetaxel—skin cancer	6.71e-05	0.000712	CcSEcCtD
Imiquimod—Chest pain—Docetaxel—skin cancer	6.71e-05	0.000712	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	6.67e-05	0.000707	CcSEcCtD
Imiquimod—Diarrhoea—Temozolomide—skin cancer	6.62e-05	0.000702	CcSEcCtD
Imiquimod—Hypersensitivity—Fluorouracil—skin cancer	6.57e-05	0.000697	CcSEcCtD
Imiquimod—Dry mouth—Docetaxel—skin cancer	6.56e-05	0.000697	CcSEcCtD
Imiquimod—Oedema—Docetaxel—skin cancer	6.43e-05	0.000683	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NRAS—skin cancer	6.41e-05	0.00165	CbGpPWpGaD
Imiquimod—Dizziness—Temozolomide—skin cancer	6.4e-05	0.000679	CcSEcCtD
Imiquimod—Infection—Docetaxel—skin cancer	6.39e-05	0.000678	CcSEcCtD
Imiquimod—Nausea—Dactinomycin—skin cancer	6.35e-05	0.000674	CcSEcCtD
Imiquimod—Shock—Docetaxel—skin cancer	6.33e-05	0.000672	CcSEcCtD
Imiquimod—Nervous system disorder—Docetaxel—skin cancer	6.31e-05	0.00067	CcSEcCtD
Imiquimod—Pruritus—Fluorouracil—skin cancer	6.31e-05	0.000669	CcSEcCtD
Imiquimod—Tachycardia—Docetaxel—skin cancer	6.28e-05	0.000666	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	6.28e-05	0.00162	CbGpPWpGaD
Imiquimod—Skin disorder—Docetaxel—skin cancer	6.25e-05	0.000663	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—HRAS—skin cancer	6.19e-05	0.00159	CbGpPWpGaD
Imiquimod—Vomiting—Temozolomide—skin cancer	6.15e-05	0.000653	CcSEcCtD
Imiquimod—Anorexia—Docetaxel—skin cancer	6.13e-05	0.000651	CcSEcCtD
Imiquimod—Rash—Temozolomide—skin cancer	6.1e-05	0.000647	CcSEcCtD
Imiquimod—Diarrhoea—Fluorouracil—skin cancer	6.1e-05	0.000647	CcSEcCtD
Imiquimod—Dermatitis—Temozolomide—skin cancer	6.1e-05	0.000647	CcSEcCtD
Imiquimod—Headache—Temozolomide—skin cancer	6.06e-05	0.000643	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—skin cancer	5.92e-05	0.00153	CbGpPWpGaD
Imiquimod—Dizziness—Fluorouracil—skin cancer	5.9e-05	0.000626	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	5.87e-05	0.00151	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Docetaxel—skin cancer	5.86e-05	0.000622	CcSEcCtD
Imiquimod—Insomnia—Docetaxel—skin cancer	5.82e-05	0.000617	CcSEcCtD
Imiquimod—Paraesthesia—Docetaxel—skin cancer	5.78e-05	0.000613	CcSEcCtD
Imiquimod—Nausea—Temozolomide—skin cancer	5.75e-05	0.00061	CcSEcCtD
Imiquimod—Dyspnoea—Docetaxel—skin cancer	5.74e-05	0.000609	CcSEcCtD
Imiquimod—Somnolence—Docetaxel—skin cancer	5.72e-05	0.000607	CcSEcCtD
Imiquimod—Vomiting—Fluorouracil—skin cancer	5.67e-05	0.000601	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—skin cancer	5.66e-05	0.000601	CcSEcCtD
Imiquimod—Rash—Fluorouracil—skin cancer	5.62e-05	0.000596	CcSEcCtD
Imiquimod—Dermatitis—Fluorouracil—skin cancer	5.62e-05	0.000596	CcSEcCtD
Imiquimod—Decreased appetite—Docetaxel—skin cancer	5.59e-05	0.000593	CcSEcCtD
Imiquimod—Headache—Fluorouracil—skin cancer	5.59e-05	0.000593	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Docetaxel—skin cancer	5.56e-05	0.000589	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—skin cancer	5.55e-05	0.000589	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—KRAS—skin cancer	5.52e-05	0.00142	CbGpPWpGaD
Imiquimod—Pain—Docetaxel—skin cancer	5.5e-05	0.000584	CcSEcCtD
Imiquimod—Feeling abnormal—Docetaxel—skin cancer	5.3e-05	0.000563	CcSEcCtD
Imiquimod—Nausea—Fluorouracil—skin cancer	5.3e-05	0.000562	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—skin cancer	5.26e-05	0.000558	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—skin cancer	5.09e-05	0.00054	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—skin cancer	5.09e-05	0.00054	CcSEcCtD
Imiquimod—TLR8—Immune System—NRAS—skin cancer	4.93e-05	0.00127	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	4.89e-05	0.00126	CbGpPWpGaD
Imiquimod—Hypersensitivity—Docetaxel—skin cancer	4.74e-05	0.000503	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—HRAS—skin cancer	4.69e-05	0.00121	CbGpPWpGaD
Imiquimod—Asthenia—Docetaxel—skin cancer	4.62e-05	0.00049	CcSEcCtD
Imiquimod—Pruritus—Docetaxel—skin cancer	4.55e-05	0.000483	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—IL6—skin cancer	4.49e-05	0.00116	CbGpPWpGaD
Imiquimod—Diarrhoea—Docetaxel—skin cancer	4.4e-05	0.000467	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.4e-05	0.00113	CbGpPWpGaD
Imiquimod—Dizziness—Docetaxel—skin cancer	4.26e-05	0.000451	CcSEcCtD
Imiquimod—TLR8—Immune System—KRAS—skin cancer	4.24e-05	0.00109	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	4.2e-05	0.00108	CbGpPWpGaD
Imiquimod—Vomiting—Docetaxel—skin cancer	4.09e-05	0.000434	CcSEcCtD
Imiquimod—Rash—Docetaxel—skin cancer	4.06e-05	0.00043	CcSEcCtD
Imiquimod—Dermatitis—Docetaxel—skin cancer	4.05e-05	0.00043	CcSEcCtD
Imiquimod—Headache—Docetaxel—skin cancer	4.03e-05	0.000428	CcSEcCtD
Imiquimod—Nausea—Docetaxel—skin cancer	3.82e-05	0.000406	CcSEcCtD
Imiquimod—TLR7—Immune System—NRAS—skin cancer	3.73e-05	0.000962	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—skin cancer	3.6e-05	0.000929	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.57e-05	0.000921	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—skin cancer	3.45e-05	0.000889	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KRAS—skin cancer	3.21e-05	0.000828	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—skin cancer	2.73e-05	0.000704	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—skin cancer	2.61e-05	0.000674	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLIN2—skin cancer	1.96e-05	0.000505	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CSPG4—skin cancer	1.58e-05	0.000407	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLIN2—skin cancer	1.51e-05	0.00039	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CSPG4—skin cancer	1.22e-05	0.000314	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO2—skin cancer	1.07e-05	0.000277	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.39e-06	0.000216	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO2—skin cancer	8.28e-06	0.000213	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ERCC2—skin cancer	6.23e-06	0.000161	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ERCC2—skin cancer	4.81e-06	0.000124	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—skin cancer	3.74e-06	9.63e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—skin cancer	2.89e-06	7.43e-05	CbGpPWpGaD
